Mason Carrico
Stock Analyst at Stephens
(0.90)
# 4,086
Out of 5,128 analysts
67
Total ratings
34.4%
Success rate
-2.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mason Carrico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYGN Myriad Genetics | Rated: Hold | $3 → $6 | $5.68 | +5.63% | 7 | Nov 12, 2026 | |
| IRTC iRhythm Holdings | Rated: Buy | $160 → $120 | $93.56 | +28.26% | 2 | Nov 11, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $65 | $59.10 | +9.98% | 6 | Nov 11, 2026 | |
| VCYT Veracyte | Rated: Buy | $55 → $40 | $24.63 | +62.40% | 6 | Nov 11, 2026 | |
| CTKB Cytek Biosciences | Rated: Buy | $6 → $7 | $5.52 | +26.81% | 5 | Nov 10, 2026 | |
| VCEL Vericel | Rated: Buy | $68 | $57.42 | +18.43% | 1 | Nov 10, 2026 | |
| ILMN Illumina | Downgraded: Hold | $110 → $275 | $209.55 | +31.23% | 9 | Oct 23, 2026 | |
| PACB Pacific Biosciences of California | Reiterated: Buy | $2 → $2.5 | $1.97 | +26.90% | 4 | Oct 23, 2026 | |
| GH Guardant Health | Reiterated: Buy | $63 → $195 | $154.86 | +25.92% | 4 | Aug 4, 2026 | |
| ATEC Alphatec Holdings | Initiated Coverage: Buy | $15 | $7.06 | +112.46% | 1 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $90 | $68.62 | +31.16% | 1 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $145 | $246.03 | -41.06% | 2 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $11 | $16.54 | n/a | 4 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $70 | $23.51 | n/a | 1 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $18 | $79.81 | n/a | 7 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $34.50 | n/a | 3 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $322.94 | n/a | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.1 → $1.25 | $2.31 | n/a | 2 | May 24, 2022 |
Myriad Genetics
Nov 12, 2026
Rated: Hold
Price Target: $3 → $6
Current: $5.68
Upside: +5.63%
iRhythm Holdings
Nov 11, 2026
Rated: Buy
Price Target: $160 → $120
Current: $93.56
Upside: +28.26%
10x Genomics
Nov 11, 2026
Reiterated: Hold
Price Target: $65
Current: $59.10
Upside: +9.98%
Veracyte
Nov 11, 2026
Rated: Buy
Price Target: $55 → $40
Current: $24.63
Upside: +62.40%
Cytek Biosciences
Nov 10, 2026
Rated: Buy
Price Target: $6 → $7
Current: $5.52
Upside: +26.81%
Vericel
Nov 10, 2026
Rated: Buy
Price Target: $68
Current: $57.42
Upside: +18.43%
Illumina
Oct 23, 2026
Downgraded: Hold
Price Target: $110 → $275
Current: $209.55
Upside: +31.23%
Pacific Biosciences of California
Oct 23, 2026
Reiterated: Buy
Price Target: $2 → $2.5
Current: $1.97
Upside: +26.90%
Guardant Health
Aug 4, 2026
Reiterated: Buy
Price Target: $63 → $195
Current: $154.86
Upside: +25.92%
Alphatec Holdings
Jul 23, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $7.06
Upside: +112.46%
Feb 25, 2026
Rated: Buy
Price Target: $90
Current: $68.62
Upside: +31.16%
Jan 2, 2026
Reiterated: Buy
Price Target: $115 → $145
Current: $246.03
Upside: -41.06%
Sep 2, 2025
Reiterated: Buy
Price Target: $18 → $11
Current: $16.54
Upside: n/a
Jul 9, 2025
Initiated Coverage: Buy
Price Target: $70
Current: $23.51
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $15 → $18
Current: $79.81
Upside: n/a
May 8, 2023
Reiterated: Buy
Price Target: $41
Current: $34.50
Upside: n/a
Dec 16, 2022
Reiterated: Buy
Price Target: n/a
Current: $322.94
Upside: n/a
May 24, 2022
Downgraded: Hold
Price Target: $3.1 → $1.25
Current: $2.31
Upside: n/a